1 week Ago By ABMN Staff
Orion Portfolio Solutions LLC grew its stake in iShares U.S. Pharmaceuticals ETF ( NYSEARCA:IHE – Free Report ) by 3.
2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,465 shares of the company’s stock after acquiring an additional 321 shares during the quarter. Orion Portfolio Solutions LLC’s holdings in iShares U.
S. Pharmaceuticals ETF were worth $688,000 at the end of the most recent quarter. A number of other institutional investors have also recently modified their holdings of IHE.
Janney Montgomery Scott LLC boosted its stake in iShares U.S. Pharmaceuticals ETF by 4.
1% in the 4th quarter. Janney Montgomery Scott LLC now owns 6,699 shares of the company’s stock worth $440,000 after purchasing an additional 261 shares in the last quarter. HighTower Advisors LLC lifted its stake in shares of iShares U.
S. Pharmaceuticals ETF by 1.9% in the fourth quarter.
HighTower Advisors LLC now owns 13,653 shares of the company’s stock worth $897,000 after buying an additional 261 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its holdings in shares of iShares U.S.
Pharmaceuticals ETF by 11.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,589 shares of the company’s stock valued at $253,000 after buying an additional 356 shares during the last quarter.
Atala Financial Inc bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at approximately $25,000.
Finally, Sequoia Financial Advisors LLC raised its holdings in iShares U.S. Pharmaceuticals ETF by 19.
1% in the 4th quarter. Sequoia Financial Advisors LLC now owns 3,433 shares of the company’s stock worth $226,000 after acquiring an additional 550 shares during the last quarter. iShares U.
S. Pharmaceuticals ETF Trading Down 5.3 % IHE stock opened at $63.
43 on Monday. The stock has a market capitalization of $558.18 million, a PE ratio of 25.
04 and a beta of 0.63. The stock’s 50 day simple moving average is $70.
18 and its 200 day simple moving average is $69.09. iShares U.
S. Pharmaceuticals ETF has a 12-month low of $62.68 and a 12-month high of $73.
28. iShares U.S.
Pharmaceuticals ETF Profile iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.
S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.
S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.
Featured Stories Want to see what other hedge funds are holding IHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares U.S.
Pharmaceuticals ETF ( NYSEARCA:IHE – Free Report ). Receive News & Ratings for iShares U.S.
Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and related companies with MarketBeat.
com's FREE daily email newsletter ..
